Publishes attack-comparison content against competitors — marketing-forward posture.
Physician licensure and lab certification are site-claimed, not independently verified.
Systemic MSC infusion is not lawfully sellable in the US and carries a library grade of D.
Published on every entry, including the top-ranked ones. A clinic with no red flags listed has not been proved clean — it has not had one found in this research pass.
Published price
$3,500 / 100M cellsVerified price
per 100M expanded cells
$2,500 per 50M for a single joint; $4,000 for fluoroscopy-guided 100M. Published on the clinic's own site — the only clinic in the seed set with fully published per-cell pricing.
ARK never bills treatment and takes no share of what a clinic charges you — you pay the clinic or vendor directly. Prices shown are their own published prices, labelled with how they were verified.
What they do
Expanded Wharton's-jelly and placental MSC: joint injection, IV protocols, fluoroscopy-guided delivery.
The evidence behind the primary service
MSC stem cells (systemic / IV) — grade D, carried unchanged from the ARK Protocol Library. A clinic's score cannot exceed 20 of 100 on service evidence, so no clinic can rank well on an unproven therapy.
There is no positive randomised efficacy trial for systemic MSC infusion in the wellness indications it is sold for. The FTC has permanently banned operators for claiming less than the industry routinely claims.
The systemic-infusion evidence base is one 30-person safety trial in frail 75-year-olds from 2017, with a non-monotonic dose response, never replicated.
Score breakdown
Price transparency25/25
Medical leadership15/25
Regulatory standing12/20
Evidence behind the primary service8/20
Disclosure & clean record1/10
Price transparency: Price published and independently sourced.
Medical leadership: Licensed Mexican physicians with a COFEPRIS-licensed lab partner — site-claimed, not independently verified.
Regulatory standing: COFEPRIS-licensed lab partner claimed by the clinic; not independently confirmed.
Evidence behind the primary service: ARK Protocol Library grade D, carried unchanged. Capped at 20 of 100 so no clinic can rank on an unproven therapy.
Disclosure & clean record: 3 documented red flags, published on this card.
Verification status
Medical leadership: Licensed Mexican physicians with a COFEPRIS-licensed lab partner — site-claimed, not independently verified.
Regulatory: COFEPRIS-licensed lab partner claimed by the clinic; not independently confirmed.
ARK Verified: No. No clinic in this directory has passed the registry check and the human call. There is no gold star anywhere in this build.
Accreditation (JCI etc.): Not captured for this entry in this research pass. Absence is scored as absence, never as good.
Outcomes / PROMs: None published. No clinic in the directory publishes complication rates.
Shortlisted as a partner candidate: per-cell pricing published, dual locations, package logistics built for US patients — the cleanest diligence profile in a category with poor hygiene overall.